United States · 
Who invested in SelSym Biotech?
SelSym Biotech's investors include National Institutes of Health and One North Carolina Small Business Program.
20252026
$3.0MGrant$500KRound
United States · Funded startup
Who invested in SelSym Biotech
Funding summaryUpdated 26 Oct 2026
$3.5Mraised across 2 rounds since 2024, from 2 sources
$3.0MGrant$500KRound
- Latest round
- Round, $500KJul 2026
- Biggest round
- $3.0MGrant · Apr 2024
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $3.0M Apr 2024
- Biggest round
- $3.0M Grant · Apr 2024
- Between rounds
- 2.3 years from the last two
The rounds
- Jul 2026Round$500K
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $500K sold, first sale Jul 2026
- Apr 2024Grant$3.0M2 new
Source recorded
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
One North Carolina Small Business ProgramInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about SelSym Biotech
How much has SelSym Biotech raised?
SelSym Biotech has raised $3.5M across 2 rounds since 2024.
When did SelSym Biotech last raise?
SelSym Biotech's most recent round, $500K, was in Jul 2026.
What was SelSym Biotech's biggest round?
SelSym Biotech's largest round on record is $3.0M (Grant), in Apr 2024.
Who backed SelSym Biotech first?
SelSym Biotech's first round on record, in Apr 2024, was backed by National Institutes of Health and One North Carolina Small Business Program.
What stage is SelSym Biotech at?
SelSym Biotech's latest named round is a Grant, in Apr 2024.
Where is SelSym Biotech based?
SelSym Biotech is based in the United States.
Companies like SelSym Biotech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.